Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.
Bresters D, Lawitschka A, Cugno C, Pötschger U, Dalissier A, Michel G, Vettenranta K, Sundin M, Al-Seraihy A, Faraci M, Sedlacek P, Versluys AB, Jenkins A, Lutz P, Gibson B, Leiper A, Diaz MA, Shaw PJ, Skinner R, O'Brien TA, Salooja N, Bader P, Peters C.
Bresters D, et al.
Bone Marrow Transplant. 2016 Nov;51(11):1482-1489. doi: 10.1038/bmt.2016.139. Epub 2016 Jun 27.
Bone Marrow Transplant. 2016.
PMID: 27348540